Ncardia attracts Series B funding
Ncardia, an drug discovery and stem cell technology company, has raised 10.5 million euros in Series B financing. Épimède led the round.
17 November 2017•1 min read
Ncardia, an drug discovery and stem cell technology company, has raised 10.5 million euros in Series B financing. Épimède led the round.
